Quantcast

Latest Coley's Toxins Stories

2005-09-27 10:16:22

NEW YORK (Reuters) - Coley Pharmaceutical Group Inc. on Tuesday said it is starting an early-stage clinical trial of an experimental drug to treat chronic Hepatitis C virus. Coley expects preliminary data from the Phase Ib study of the drug, Actilon, to be available in the second half of 2006. The study will involve 60 patients infected with the virus, who will be divided into different treatment groups over a period of three months. Some patients will take only Actilon, some will...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.